QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pursuant-to-merger-agreement-terms-concentra-merger-sub-ii-and-theseus-determine-additional-price-per-share-max-of-015share-cash-amount-paid-in-offer-is-405share

As previously announced on December 22, 2023, Concentra Biosciences, LLC ("Parent") and its wholly owned subsidiary, Co...

 small-cap-cancer-focused-theseus-pharmaceuticals-goes-private-for-over-390share-in-cash

Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Bioscien...

 dow-jumps-over-500-points-home-depot-earnings-top-views

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 500 points on Tuesday. The Dow trade...

 why-beyond-air-shares-are-trading-lower-by-around-37-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

 crude-oil-moves-higher-beauty-health-shares-plunge

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 500 points on Tuesday. The Dow traded up 1...

 nasdaq-surges-2-us-inflation-rate-slows-in-october

U.S. stocks traded higher this morning, with the Dow Jones gaining around 400 points on Tuesday. Following the market opening ...

Core News & Articles

THRX: 53% | Theseus Pharmaceuticals Announces Process To Explore Strategic Alternatives BCDA: 166% | Biocardia Announced The F...

 why-invo-bioscience-shares-are-trading-higher-by-over-31-here-are-20-stocks-moving-premarket

INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third...

 theseus-implemented-a-workforce-reduction-of-approximately-72-as-of-september-30-2023-theseus-had-cash-cash-equivalents-and-marketable-securities-of-2254m

Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on imp...

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 647 companies set new 52-week lows.

 deciphera-pharmaceuticals-sees-renewed-competitive-edge-after-theseus-pan-kit-discontinuation-analyst

Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reeva...

 theseus-pharmaceuticals-q2-eps-034-down-from-030-yoy-cash-position-of-2342m-is-expected-to-provide-cash-runway-into-2026

Theseus Pharmaceuticals (NASDAQ:THRX) reported quarterly losses of $(0.34) per share. This is a 13.33 percent decrease over los...

 why-infosys-shares-are-trading-lower-by-9-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained ...

Core News & Articles

The Dow Jones closed higher by more than 100 points on Wednesday. When insiders purchase or sell shares, it indicates their con...